USE OF NEW RESVERATROL DIMER FOR PREVENTION/THERAPY OF CIRCULATORY SYSTEM DISEASE

USE OF NEW RESVERATROL DIMER FOR PREVENTION/THERAPY OF CIRCULATORY SYSTEM DISEASE

PROBLEM TO BE SOLVED: To provide a new pharmaceutical preparation exhibiting low density lipoprotein (LDL) receptor expression-promoting action.SOLUTION: A low density lipoprotein (LDL) receptor expression-promoting agent is characterized by containing one or more kinds of compounds selected from th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MATSUI TAKEKI, YAMADA YASUMASA, MATSUKAWA TAIJI, DOI SATOSHI, KUZUMI AKINOBU, YAMADA ICHIRO
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MATSUI TAKEKI
YAMADA YASUMASA
MATSUKAWA TAIJI
DOI SATOSHI
KUZUMI AKINOBU
YAMADA ICHIRO
description PROBLEM TO BE SOLVED: To provide a new pharmaceutical preparation exhibiting low density lipoprotein (LDL) receptor expression-promoting action.SOLUTION: A low density lipoprotein (LDL) receptor expression-promoting agent is characterized by containing one or more kinds of compounds selected from the group consisting of certain resveratrol dimers and pharmaceutically acceptable salts thereof. A LDL cholesterol elevation-suppressing agent or a LDL cholesterol-lowering agent and a cholesterol metabolism-promoting agent are characterized by containing one or more kinds of compounds selected from the group consisting of resveratrol dimers represented by a specific formula and pharmaceutically acceptable salts thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2014101342A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2014101342A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2014101342A3</originalsourceid><addsrcrecordid>eNqNi0EKwjAQAHvxIOofFu9i0_YDIW5opE3iblrJqRSJJ9FC_T9W8AGe5jAz6-zSMYLTYPEKhNwjyUCugZNpkUA7Ak_Yow3G2WOoF-3jt1eGVNfI4CgCRw7YLgujZNxmq_v4mNPux0221xhUfUjTa0jzNN7SM72Hsy9yUYlclFUhy7-iDykXMAw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF NEW RESVERATROL DIMER FOR PREVENTION/THERAPY OF CIRCULATORY SYSTEM DISEASE</title><source>esp@cenet</source><creator>MATSUI TAKEKI ; YAMADA YASUMASA ; MATSUKAWA TAIJI ; DOI SATOSHI ; KUZUMI AKINOBU ; YAMADA ICHIRO</creator><creatorcontrib>MATSUI TAKEKI ; YAMADA YASUMASA ; MATSUKAWA TAIJI ; DOI SATOSHI ; KUZUMI AKINOBU ; YAMADA ICHIRO</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a new pharmaceutical preparation exhibiting low density lipoprotein (LDL) receptor expression-promoting action.SOLUTION: A low density lipoprotein (LDL) receptor expression-promoting agent is characterized by containing one or more kinds of compounds selected from the group consisting of certain resveratrol dimers and pharmaceutically acceptable salts thereof. A LDL cholesterol elevation-suppressing agent or a LDL cholesterol-lowering agent and a cholesterol metabolism-promoting agent are characterized by containing one or more kinds of compounds selected from the group consisting of resveratrol dimers represented by a specific formula and pharmaceutically acceptable salts thereof.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140605&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014101342A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140605&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014101342A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MATSUI TAKEKI</creatorcontrib><creatorcontrib>YAMADA YASUMASA</creatorcontrib><creatorcontrib>MATSUKAWA TAIJI</creatorcontrib><creatorcontrib>DOI SATOSHI</creatorcontrib><creatorcontrib>KUZUMI AKINOBU</creatorcontrib><creatorcontrib>YAMADA ICHIRO</creatorcontrib><title>USE OF NEW RESVERATROL DIMER FOR PREVENTION/THERAPY OF CIRCULATORY SYSTEM DISEASE</title><description>PROBLEM TO BE SOLVED: To provide a new pharmaceutical preparation exhibiting low density lipoprotein (LDL) receptor expression-promoting action.SOLUTION: A low density lipoprotein (LDL) receptor expression-promoting agent is characterized by containing one or more kinds of compounds selected from the group consisting of certain resveratrol dimers and pharmaceutically acceptable salts thereof. A LDL cholesterol elevation-suppressing agent or a LDL cholesterol-lowering agent and a cholesterol metabolism-promoting agent are characterized by containing one or more kinds of compounds selected from the group consisting of resveratrol dimers represented by a specific formula and pharmaceutically acceptable salts thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKwjAQAHvxIOofFu9i0_YDIW5opE3iblrJqRSJJ9FC_T9W8AGe5jAz6-zSMYLTYPEKhNwjyUCugZNpkUA7Ak_Yow3G2WOoF-3jt1eGVNfI4CgCRw7YLgujZNxmq_v4mNPux0221xhUfUjTa0jzNN7SM72Hsy9yUYlclFUhy7-iDykXMAw</recordid><startdate>20140605</startdate><enddate>20140605</enddate><creator>MATSUI TAKEKI</creator><creator>YAMADA YASUMASA</creator><creator>MATSUKAWA TAIJI</creator><creator>DOI SATOSHI</creator><creator>KUZUMI AKINOBU</creator><creator>YAMADA ICHIRO</creator><scope>EVB</scope></search><sort><creationdate>20140605</creationdate><title>USE OF NEW RESVERATROL DIMER FOR PREVENTION/THERAPY OF CIRCULATORY SYSTEM DISEASE</title><author>MATSUI TAKEKI ; YAMADA YASUMASA ; MATSUKAWA TAIJI ; DOI SATOSHI ; KUZUMI AKINOBU ; YAMADA ICHIRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2014101342A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MATSUI TAKEKI</creatorcontrib><creatorcontrib>YAMADA YASUMASA</creatorcontrib><creatorcontrib>MATSUKAWA TAIJI</creatorcontrib><creatorcontrib>DOI SATOSHI</creatorcontrib><creatorcontrib>KUZUMI AKINOBU</creatorcontrib><creatorcontrib>YAMADA ICHIRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MATSUI TAKEKI</au><au>YAMADA YASUMASA</au><au>MATSUKAWA TAIJI</au><au>DOI SATOSHI</au><au>KUZUMI AKINOBU</au><au>YAMADA ICHIRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF NEW RESVERATROL DIMER FOR PREVENTION/THERAPY OF CIRCULATORY SYSTEM DISEASE</title><date>2014-06-05</date><risdate>2014</risdate><abstract>PROBLEM TO BE SOLVED: To provide a new pharmaceutical preparation exhibiting low density lipoprotein (LDL) receptor expression-promoting action.SOLUTION: A low density lipoprotein (LDL) receptor expression-promoting agent is characterized by containing one or more kinds of compounds selected from the group consisting of certain resveratrol dimers and pharmaceutically acceptable salts thereof. A LDL cholesterol elevation-suppressing agent or a LDL cholesterol-lowering agent and a cholesterol metabolism-promoting agent are characterized by containing one or more kinds of compounds selected from the group consisting of resveratrol dimers represented by a specific formula and pharmaceutically acceptable salts thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2014101342A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USE OF NEW RESVERATROL DIMER FOR PREVENTION/THERAPY OF CIRCULATORY SYSTEM DISEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A49%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MATSUI%20TAKEKI&rft.date=2014-06-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2014101342A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true